Clinical and epidemiological characterization of diabetic patients with dyslipidemia
Keywords:
DIABETES MELLITUS, DYSLIPIDEMIAS, HYPERTRIGLYCERIDEMIA, OBESITY.Abstract
Introduction: dyslipidemia affects most patients with diabetes mellitus, in whom lipid alteration is often present from the prediabetes stage. However, although it is a modifiable risk factor, it is not always controlled.
Objective: to clinically and epidemiologically characterize diabetic patients with dyslipidemia.
Methods: an observational, descriptive, cross-sectional, cross-sectional study was carried out with patients attended at the Basic Group No. II, of the University Polyclinic “Luis A. Turcios Lima”, in the period from November 2020 to June 2021. The universe consisted of 53 patients, coinciding with the sample, and descriptive and inferential statistics were applied to the data obtained.
Results: in the study series, the female sex and the age group 60 to 69 years predominated. Grade II obesity was the most frequent excess malnutrition. Alterations in hematological variables were observed, with hypertriglyceridemia being the most prevalent type of dyslipidemia. Neuropathy and diabetic retinopathy were the most frequent organic affections, with a predominance of moderately functional families.
Conclusions: in the study carried out, grade II obesity was the most frequent excess malnutrition among diabetic patients with dyslipidemia. The most frequent organic involvement was diabetic neuropathy.
Downloads
References
1. Valencia Leal AA, Flórez Gutiérrez LG, Nohemi Pérez E, Valencia Leal AV. Tratamiento y control de la diabetes con intervención de estilo de vida en pacientes ambulatorios: Serie de Casos y Actualización. Rev. Fac. Med. Hum [Internet].2022 Ene [citado 29/12/2021]; 22(1): 211-215. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308-05312022000100211
2. Blanco Naranjo EG, Chavarría Campos GF, Garita Fallas YM. Estilo de vida saludable en diabetes mellitus tipo 2: beneficios en el manejo crónico. Rev.méd.sinerg [Internet]. 1 de febrero de 2021 [citado 30/12/2021]; 6(2): e639. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/639
3. Inzucchi S, Lupsa B. Clinical presentation, diagnosis, and initial evaluation of diabetes mellitus in adults [Internet]. Uptodate; 2020 [citado 30/12/2021]. Disponible en: https://www.uptodate.com/contents/clinical-presentation-diagnosis-and-initial-evaluation-of-diabetes-mellitus-in-adults
4. Saijo Y, Okada H, Hamaguchi M, Habu M. The Risk Factors for Development of Type 2 Diabetes: Panasonic Cohort Study 4. Int. J. Environ. Res. Public Health [Internet]. 2022 [citado 29/02/2022]; 19: 571. Disponible en:
5. Russo MP, Grande-Ratti MF, Burgos MA, Molaro AA, Bonella MB. Prevalencia de diabetes, características epidemiológicas y complicaciones vasculares. Archivos de Cardiología de México [Internet]. 2023 Feb 2 [citado 11/12/2023]; 93(1): 30-36. Disponible en: http://ncbi.nlm.nih.gov/pmc/articles/PMC10161833/
6. MINSAP. Anuario Estadístico de Salud 2022 [Internet]. La Habana; 2023 [citado 05/12/2023]. Disponible en: https://bvscuba.sld.cu/anuario-estadistico-de-cuba/
7. Mendoza Romo MA. Prevalencia mundial de la diabetes mellitus tipo 2 y su relación con el índice de desarrollo humano. Revista Panamericana de Salud Pública [Internet]. 2018 [citado 22/08/2022]; 41: 103. Disponible en: https://doi.org/10.26633/RPSP.2017.103.
8. Torres Jumbo RF, Acosta Navia MK, Rodríguez Avilés DA. Complicaciones agudas de la diabetes tipo 2. RECIMUNDO [Internet]. 2020 [Citado 24 jul 2019]; 4(1): 46-57. Disponible en: https://dialnet.unirioja.es/descarga/articulo/7402279.pdf
9. Hidalgo Villavicencio G. Dislipidemia Asociado a Diabetes Mellitus en Adultos con y sin Sobrepeso de la Ciudad de Jipijapa. Pol. Con. [Internet]. 2022 [Citado 24/07/2019]; 7(3): 1073-1099. Disponible en:
https://polodelconocimiento.com/ojs/index.php/es/article/download/3779/8727
10. González Pedroso M, Torres Rodríguez M, Ferrer Arrocha M, Alonso Martínez M, Pérez Assef H. Prevalencia de alteraciones del metabolismo glucídico en familiares de primer grado de pacientes diabéticos tipo 2. Rev cubana med [Internet]. 2020 Jun [citado 16/09/2020]; 59(2): e8859. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034˗75232020000200002&lng=es.Epub 01-Jun-2020.
11. Lara O. Interacción genoma-ambiente en la diabetes mellitus tipo 2 Acta Médica del Centro [Internet]. 2018 [citado 24/07/2022]; 12(4): 429-439. Disponible en: https://revactamedicacentro.sld.cu/index.php/amc/article/download/948/1200
12. Ruiz López J, Letamendi Velasco J, Calderón León R. Prevalencia de dislipidemias en pacientes obesos. MEDISAN [Internet]. 2020 Abr [citado 24/02/2022]; 24(2): 211-222. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192020000200211
13. Díaz Aragón A, Fernández Barros CL, Enciso Muñoz JM, Ceballos Reyes G, Gutiérrez Salmeán G, León Hernández FJ, et al. Posicionamiento en torno al diagnóstico y tratamiento de las dislipidemias. Rev Mex Cardiol [Internet]. 2018 [citado 28/11/2019] 29(Supl 3): s148-s168. Disponible en: https://www.medigraphic.com/pdfs/cardio/h-2018/hs183a.pdf
14. Villalta Darwing B, Miranda Tibisay AM, Hernández Gustavo PM. Dislipidemia en Diabetes Mellitus Tipo 1: Características y factores de riesgo asociados en pacientes del Instituto Autónomo Hospital Universitario de Los Andes, Mérida, Venezuela. Rev. Venez. Endocrinol. Metab [Internet]. 2017 Jun [citado 24/02/2022]; 15(2): 86-97. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S1690˗31102017000200004&lng=es.
15. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, De Boer MJ, et al. Guías de práctica clínica sobre diabetes, prediabetes y enfermedades cardiovasculares. Rev Esp Cardiol [Internet]. 2021 [citado 24/02/2022]; 60(5): 525.e1-e64. Disponible en: https://www.revespcardiol.org/index.php?p=revista&pii=13106365&tipo=pdf-simple
16. Reyes Sanamé F, Pérez Alvares M, Medina Arce M, Navarro Caboverde Y, Fernández Mendoza A. Aspectos clínicos y epidemiológicos de pacientes ingresados por diabetes mellitus de tipo 2 en el hospital de Moa. MEDISAN [Internet]. 2020 Dic [citado 24/02/2022]; 24(6): 1143-1156. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029˗30192020000601143&lng=es. Epub 30-Nov-20
17. Torres E, Arévalo H, Suarez I, Vega N. Perfil clínico de pacientes atendidos con diabetes mellitus tipo 2 en un programa de reversión. Rev. Fac. Med. Hum [Internet]. 2021 Ene [citado 24/02/2022]; 21(1): 145-150. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308˗05312021000100145&lng=es
18. Gradinaru D, Khaddour H, Margina D, Ungurianu A, Borsa C, Ionescu C, Prada GI, Usher J, Elshimali Y. Insulin-Leptin Axis, Cardiometabolic Risk and Oxidative Stress in Elderly with Metabolic Syndrome. Exp Clin Endocrinol Diabetes [Internet]. 2018 [citado 29/12/2021]: s/v. Disponible en:
https://pubmed.ncbi.nlm.nih.gov/29421825/
19. Cuevas A. Dislipidemia diabética. Revista Médica Clínica Las Condes [Internet]. 2016 [citado 29/02/2022]: 27(2): 152-159. Disponible en: https://www.sciencedirect.com/science/article/pii/S0716864016300049
20. Bell CJ, George CW, Garcia CME. Características clínico-epidemiológicas en pacientes con síndrome metabólico. MediSan [Internet]. 2020 [citado: 29/02/2022]; 24(04): 669-681. Disponible en:
https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=99043
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
